Lupus Landmark Study: A Prospective Registry and Biorepository

Recruiting now

Conditions studied: Systemic Lupus Erythematosus (SLE), Lupus Nephritis, Neuropsychiatric Systemic Lupus Erythematosus

In brief

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Key facts

Study ID

NCT05934149

Run by

Lupus Research Alliance

People needed

3500

Starts

2023-06-28

Expected to finish

2035-12-01

Last updated by the study team

2026-04-15

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to understand and comply with study procedures and voluntarily sign a written informed consent document
• Age 18 years or older at the time of enrollment
• Fulfill criteria for SLE based on one or more of the following classifications systems:
• Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment.

You may not qualify if…

• Not able to obtain consent
• Not able to meet protocol visit requirements
• Pregnant at the time of enrollment

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)
• University of Arizona — Tucson, Arizona, United States (enrolling)
• Wallace Rheumatic Studies Center — Beverly Hills, California, United States (enrolling)
• University Health Network/Toronto Western Hospital — Toronto, Ontario, Canada (enrolling)
• McGill University Health Centre — Montreal, Quebec, Canada (enrolling)
• CHU de Québec - Université Laval — Québec, Quebec, Canada (enrolling)
• University of Miami — Miami, Florida, United States (enrolling)
• Emory University — Atlanta, Georgia, United States (enrolling)
• University of Chicago — Chicago, Illinois, United States (enrolling)
• Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)
• University of Massachusetts Memorial Health — Worcester, Massachusetts, United States (enrolling)
• Washington University — St Louis, Missouri, United States (enrolling)
• The Feinstein Institutes for Medical Research — Manhasset, New York, United States (enrolling)
• Northwell Health — New York, New York, United States (enrolling)
• SUNY Upstate — Syracuse, New York, United States (enrolling)
• UNC Chapel Hill — Chapel Hill, North Carolina, United States (enrolling)
• The MetroHealth System — Cleveland, Ohio, United States (enrolling)
• Vanderbilt University Medical Center — Nashville, Tennessee, United States (enrolling)
• UT Southwestern Medical Center — Dallas, Texas, United States (enrolling)
• University of Calgary — Calgary, Alberta, Canada (enrolling)
• University of Alberta Hospital — Edmonton, Alberta, Canada (enrolling)
• University of Manitoba — Winnipeg, Manitoba, Canada (enrolling)
• UCLA — Los Angeles, California, United States
• Georgetown University — Washington D.C., District of Columbia, United States
• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.